New Delhi, (PTI) A new technique that uses whole genome sequencing can help personalise drug therapy in tuberculosis (TB) patients and ensure complete treatment for the disease, according to a biotechnologist.
Anirvan Chatterjee, founder & CEO of HaystackAnalytics, a start-up incubated at the Indian Institute of Technology (IIT) Bombay, noted that the method provides a means for conclusively ascertaining drug resistance in a TB patient.
Complete treatment of TB patients is significant as being a transmissible disease, TB presents the risk of spreading and evolving into a superior drug-resistant version of itself.
